Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Change in Cash (2016 - 2025)

Historic Change in Cash for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $45.6 million.

  • AC Immune's Change in Cash rose 19227.07% to $45.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.7 million, marking a year-over-year increase of 25888.19%. This contributed to the annual value of -$46.3 million for FY2024, which is 18471.92% down from last year.
  • Per AC Immune's latest filing, its Change in Cash stood at $45.6 million for Q3 2025, which was up 19227.07% from $9.7 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Change in Cash ranged from a high of $54.2 million in Q4 2023 and a low of -$51.2 million during Q2 2021
  • In the last 5 years, AC Immune's Change in Cash had a median value of -$11.6 million in 2021 and averaged -$6.6 million.
  • Per our database at Business Quant, AC Immune's Change in Cash crashed by 140862.36% in 2021 and then soared by 51477.88% in 2023.
  • Quarter analysis of 5 years shows AC Immune's Change in Cash stood at -$11.7 million in 2021, then dropped by 11.48% to -$13.1 million in 2022, then soared by 514.78% to $54.2 million in 2023, then crashed by 95.98% to $2.2 million in 2024, then skyrocketed by 1991.91% to $45.6 million in 2025.
  • Its Change in Cash was $45.6 million in Q3 2025, compared to $9.7 million in Q2 2025 and -$17.8 million in Q1 2025.